연구성과로 돌아가기

2025 연구성과별 연구자 정보 (943 / 1187)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
RUNX1 FUNCTIONS AS A CRITICAL ANABOLIC REGULATOR IN THE PREVENTION OF ARTICULAR CARTILAGE DEGENERATION VIA THE TGF-Β SIGNALING PATHWAY Choi, Poo-Reum Choi, PR 5 Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea
RUNX1 FUNCTIONS AS A CRITICAL ANABOLIC REGULATOR IN THE PREVENTION OF ARTICULAR CARTILAGE DEGENERATION VIA THE TGF-Β SIGNALING PATHWAY Park, Min Park, M 6 Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea
RUNX1 FUNCTIONS AS A CRITICAL ANABOLIC REGULATOR IN THE PREVENTION OF ARTICULAR CARTILAGE DEGENERATION VIA THE TGF-Β SIGNALING PATHWAY Kim, Hyun-Ju Kim, HJ 7 Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea
RUNX1 FUNCTIONS AS A CRITICAL ANABOLIC REGULATOR IN THE PREVENTION OF ARTICULAR CARTILAGE DEGENERATION VIA THE TGF-Β SIGNALING PATHWAY Kim, Hee-Jun Kim, HJ 8 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Orthoped Surg, Daegu, South Korea
RUNX1 FUNCTIONS AS A CRITICAL ANABOLIC REGULATOR IN THE PREVENTION OF ARTICULAR CARTILAGE DEGENERATION VIA THE TGF-Β SIGNALING PATHWAY Choi, Je-Yong Choi, JY 9 Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea AAR-7334-2021 Choi, Je-Yong
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Antozzi, Carlo Antozzi, C 1 Fdn IRCCS Carlo Besta Neurol Inst, Neuromuscular Dis & Neuroimmunol Unit, Milan, Italy sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Antozzi, Carlo Antozzi, C 1 IRCCS Carlo Besta Neurol Inst Fdn, Apheresis & Immunotherapy Unit, Milan, Italy sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Vu, Tuan Vu, T 2 Univ South Florida Hlth, Morsani Coll Med, Dept Neurol, Tampa, FL USA sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Ramchandren, Sindhu Ramchandren, S 3 교신저자 Janssen Res & Dev, Titusville, NJ 08560 USA D-6942-2012 Ramchandren, Sindhu sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Nowak, Richard J. Nowak, RJ 4 Yale Univ, Sch Med, Dept Neurol, New Haven, CT USA sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Farmakidis, Constantine Farmakidis, C 5 Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS USA AAX-6847-2020 Farmakidis, Constantine sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Bril, Vera Bril, V 6 Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada ABA-6509-2020 BRIL, vera sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study De Bleecker, Jan De Bleecker, J 7 Ghent Univ Hosp, Dept Neurol, Ghent, Belgium sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Yang, Huan Yang, H 8 Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China sramcha4@its.jnj.com;
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study Minks, Eduard Minks, E 9 Masaryk Univ, Dept Neurol, Brno, Czech Republic sramcha4@its.jnj.com;
페이지 이동: